Sanofi, AstraZeneca and two leading trade groups want clarity around an appellate decision that called for Teva to delist ...
The French drugmaker said it had entered a mandate with an “investment service provider”, with the purchase occurring between ...
GlobalData on MSN14h
Novo Nordisk’s haemophilia A drug stops bleeds in 74% of childrenNovo Nordisk’s haemophilia A therapy Mim8 stopped bleeding completely in 74.3% of children in a Phase III trial. The ...
According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...
Sanofi announced its intention to execute a share buyback program in 2025 of €5 billion, preferably through block trades and in the open market with the purpose of cancellation. A first tranche of ...
French pharmaceutical and healthcare company Sanofi on Friday announced a share buyback plan worth up to €2 billion ($2.08 ...
Sanofi (SNY), a French pharmaceutical and healthcare company, Friday announced that it is executing the second tranche of its share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback